STOCK TITAN

Gilead Sciences: Innovative Approaches to Healthcare Can Remove Barriers

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Gilead Sciences, a biopharmaceutical company focused on developing innovative medicines for unmet medical needs, emphasizes the importance of removing barriers to healthcare access. Johanna Mercier, Chief Commercial Officer, highlights Gilead's efforts to improve health equity and increase access to life-changing therapies. These initiatives align with the company's commitment to responsible business practices.

Gilead operates in over 35 countries globally, with its headquarters in Foster City, California. The company's mission is to transform and simplify care for people with life-threatening illnesses worldwide, focusing on areas of unmet medical need.

Loading...
Loading translation...

Positive

  • Global presence in over 35 countries, indicating wide market reach
  • Focus on developing innovative medicines for unmet medical needs
  • Commitment to improving health equity and increasing access to therapies

Negative

  • None.

News Market Reaction 1 Alert

-0.72% News Effect

On the day this news was published, GILD declined 0.72%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NORTHAMPTON, MA / ACCESSWIRE / September 4, 2024 / Transformative medicines have the greatest impact when they reach the people who need them most.

Here, Johanna Mercier, Chief Commercial Officer, shares how Gilead works to help remove barriers to care, improve health equity and increase access to life-changing therapies - all of which underscore our commitment to being a responsible company.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences



View the original press release on accesswire.com

FAQ

What is Gilead Sciences' (GILD) approach to healthcare access?

Gilead Sciences (GILD) focuses on removing barriers to healthcare access, improving health equity, and increasing access to life-changing therapies. The company aims to transform and simplify care for people with life-threatening illnesses globally.

Who is the Chief Commercial Officer of Gilead Sciences (GILD)?

Johanna Mercier is the Chief Commercial Officer of Gilead Sciences (GILD).

Where is Gilead Sciences (GILD) headquartered?

Gilead Sciences (GILD) is headquartered in Foster City, California.

In how many countries does Gilead Sciences (GILD) operate?

Gilead Sciences (GILD) operates in more than 35 countries worldwide.
Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Latest SEC Filings

GILD Stock Data

154.71B
1.24B
0.1%
90.75%
1.42%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
FOSTER CITY